ArticleCureus2025
Incidental Primary Ovarian Squamous Cell Carcinoma Arising in Endometriosis Presenting As Adenomyosis-Related Abnormal Uterine Bleeding.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Dual TP53 mutations in ovarian high-grade serous carcinoma combined with squamous cell carcinoma: a case report and systematic literature review.Journal of ovarian research · 2026Pooled it
- Synchronous primary HPV-associated squamous cell carcinomas of the cervix and fallopian tube: a case report.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adenomyosis often coexists with endometriosis, which primarily involves the ovary and can lead to endometriosis‑associated ovarian cancers, most commonly endometrioid and clear‑cell carcinomas. Ovarian squamous cell carcinoma (OSCC) arising in endometriosis is exceedingly rare, lacks established treatment guidelines, and carries a poor prognosis despite only sporadic reports in the literature. We describe a 45‑year‑old multiparous woman with a three‑month history of abnormal uterine bleeding. Speculum examination revealed a bleeding polypoid cervical mass, and transvaginal ultrasound confirmed adenomyosis. Persistent bleeding refractory to polypectomy and resultant severe anemia prompted total abdominal hysterectomy with bilateral salpingo‑oophorectomy. Unexpected histopathology and immunohistochemistry revealed a primary, poorly differentiated OSCC of the left ovary arising from endometriosis, extending into the left fallopian tube; the uterus, cervix, right adnexa, and ovarian capsule were uninvolved. The tumor was staged International Federation of Gynecology and Obstetrics IIA, and the patient received six cycles of carboplatin plus paclitaxel. At 15 months postoperatively, she remains disease‑free. This case underscores how adenomyosis can mask an underlying ovarian malignancy and illustrates the rare occurrence of OSCC in endometriosis. Awareness of such presentations should prompt thorough histological evaluation, and we emphasize the urgent need to develop treatment protocols for rare, aggressive histotypes. We also review the existing literature to contextualize this uncommon pathology and its clinical implications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.